Copyright Reports & Markets. All rights reserved.

Global Atezolizumab Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 Atezolizumab Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Use: Single Drug
      • 1.2.2 Use: Chemotherapy Combination
    • 1.3 Market Analysis by Applications
      • 1.3.1 Bladder Cancer
      • 1.3.2 Lung Cancer
      • 1.3.3 Advanced Triple-negative Breast Cancer
      • 1.3.4 Head and Neck Cancer
      • 1.3.5 Urothelial Carcinoma
      • 1.3.6 Renal Cell Carcinoma
      • 1.3.7 Hepatocellular Carcinoma (HCC)
      • 1.3.8 Other
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Genentech (Roche)
      • 2.1.1 Business Overview
      • 2.1.2 Atezolizumab Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Genentech (Roche) Atezolizumab Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Atezolizumab Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Atezolizumab Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Atezolizumab Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Atezolizumab Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Atezolizumab Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Atezolizumab Market Analysis by Regions

    • 4.1 Global Atezolizumab Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Atezolizumab Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Atezolizumab Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Atezolizumab Sales and Growth Rate (2014-2019)
    • 4.3 Europe Atezolizumab Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Atezolizumab Sales and Growth Rate (2014-2019)
    • 4.5 South America Atezolizumab Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Atezolizumab Sales and Growth Rate (2014-2019)

    5 North America Atezolizumab by Country

    • 5.1 North America Atezolizumab Sales, Revenue and Market Share by Country
      • 5.1.1 North America Atezolizumab Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Atezolizumab Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Atezolizumab Sales and Growth Rate (2014-2019)
    • 5.3 Canada Atezolizumab Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Atezolizumab Sales and Growth Rate (2014-2019)

    6 Europe Atezolizumab by Country

    • 6.1 Europe Atezolizumab Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Atezolizumab Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Atezolizumab Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Atezolizumab Sales and Growth Rate (2014-2019)
    • 6.3 UK Atezolizumab Sales and Growth Rate (2014-2019)
    • 6.4 France Atezolizumab Sales and Growth Rate (2014-2019)
    • 6.5 Russia Atezolizumab Sales and Growth Rate (2014-2019)
    • 6.6 Italy Atezolizumab Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Atezolizumab by Country

    • 7.1 Asia-Pacific Atezolizumab Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Atezolizumab Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Atezolizumab Revenue and Market Share by Country (2014-2019)
    • 7.2 China Atezolizumab Sales and Growth Rate (2014-2019)
    • 7.3 Japan Atezolizumab Sales and Growth Rate (2014-2019)
    • 7.4 Korea Atezolizumab Sales and Growth Rate (2014-2019)
    • 7.5 India Atezolizumab Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Atezolizumab Sales and Growth Rate (2014-2019)

    8 South America Atezolizumab by Country

    • 8.1 South America Atezolizumab Sales, Revenue and Market Share by Country
      • 8.1.1 South America Atezolizumab Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Atezolizumab Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Atezolizumab Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Atezolizumab Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Atezolizumab Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Atezolizumab by Countries

    • 9.1 Middle East and Africa Atezolizumab Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Atezolizumab Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Atezolizumab Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Atezolizumab Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Atezolizumab Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Atezolizumab Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Atezolizumab Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Atezolizumab Sales and Growth Rate (2014-2019)

    10 Global Atezolizumab Market Segment by Type

    • 10.1 Global Atezolizumab Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Atezolizumab Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Atezolizumab Revenue and Market Share by Type (2014-2019)
    • 10.2 Use: Single Drug Sales Growth and Price
      • 10.2.1 Global Use: Single Drug Sales Growth (2014-2019)
      • 10.2.2 Global Use: Single Drug Price (2014-2019)
    • 10.3 Use: Chemotherapy Combination Sales Growth and Price
      • 10.3.1 Global Use: Chemotherapy Combination Sales Growth (2014-2019)
      • 10.3.2 Global Use: Chemotherapy Combination Price (2014-2019)

    11 Global Atezolizumab Market Segment by Application

    • 11.1 Global Atezolizumab Sales Market Share by Application (2014-2019)
    • 11.2 Bladder Cancer Sales Growth (2014-2019)
    • 11.3 Lung Cancer Sales Growth (2014-2019)
    • 11.4 Advanced Triple-negative Breast Cancer Sales Growth (2014-2019)
    • 11.5 Head and Neck Cancer Sales Growth (2014-2019)
    • 11.6 Urothelial Carcinoma Sales Growth (2014-2019)
    • 11.7 Renal Cell Carcinoma Sales Growth (2014-2019)
    • 11.8 Hepatocellular Carcinoma (HCC) Sales Growth (2014-2019)
    • 11.9 Other Sales Growth (2014-2019)

    12 Atezolizumab Market Forecast (2019-2024)

    • 12.1 Global Atezolizumab Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Atezolizumab Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Atezolizumab Market Forecast (2019-2024)
      • 12.2.2 Europe Atezolizumab Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Atezolizumab Market Forecast (2019-2024)
      • 12.2.4 South America Atezolizumab Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Atezolizumab Market Forecast (2019-2024)
    • 12.3 Atezolizumab Market Forecast by Type (2019-2024)
      • 12.3.1 Global Atezolizumab Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Atezolizumab Market Share Forecast by Type (2019-2024)
    • 12.4 Atezolizumab Market Forecast by Application (2019-2024)
      • 12.4.1 Global Atezolizumab Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Atezolizumab Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Scope of the Report:
      The worldwide market for Atezolizumab is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
      This report focuses on the Atezolizumab in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Market Segment by Manufacturers, this report covers
      Genentech (Roche)

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia etc.)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Use: Single Drug
      Use: Chemotherapy Combination

      Market Segment by Applications, can be divided into
      Bladder Cancer
      Lung Cancer
      Advanced Triple-negative Breast Cancer
      Head and Neck Cancer
      Urothelial Carcinoma
      Renal Cell Carcinoma
      Hepatocellular Carcinoma (HCC)
      Other

      The content of the study subjects, includes a total of 15 chapters:
      Chapter 1, to describe Atezolizumab product scope, market overview, market opportunities, market driving force and market risks.
      Chapter 2, to profile the top manufacturers of Atezolizumab, with price, sales, revenue and global market share of Atezolizumab in 2017 and 2018.
      Chapter 3, the Atezolizumab competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
      Chapter 4, the Atezolizumab breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
      Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
      Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
      Chapter 12, Atezolizumab market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
      Chapter 13, 14 and 15, to describe Atezolizumab sales channel, distributors, customers, research findings and conclusion, appendix and data source.

      Buy now